Showing results (1571-1580 of 1,634) with videos related to

Sort By:
Pageof 164
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Plos Biology|December 5, 2023
Topological data analysis reveals a core gene expression backbone that defines form and function across flowering plantsSourabh Palande, Joshua A M Kaste, Miles D Roberts, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
Blood|March 11, 2025
Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaNatalie Wuliji, Salene M W Jones, Ted A Gooley, et al.
Geophysical Research Letters|August 8, 2017
Microphysical explanation of the RH-dependent water affinity of biogenic organic aerosol and its importance for climateN Rastak, A Pajunoja, J C Acosta Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2021
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic MalignanciesStephen M Ansell, Michael B Maris, Alexander M Lesokhin, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KJacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Annals of the Rheumatic Diseases|May 5, 2011
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseasesCarla G S Saad, Eduardo F Borba, Nadia E Aikawa, et al.
Pageof 164